<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23739703</article-id>
      <article-id pub-id-type="pmc">3750892</article-id>
      <article-id pub-id-type="doi">10.1590/S0365-05962013000200014</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Rosai-Dorfman disease presenting with extensive cutaneous
manifestation - Case report<xref ref-type="fn" rid="fn01"><sup>*</sup></xref></article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Doen&#xE7;a de Rosai-Dorfman com manifesta&#xE7;&#xE3;o cut&#xE2;nea extensa - Relato de
caso</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Leal</surname>
            <given-names>Paula Azevedo Borges</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Adriano</surname>
            <given-names>Adrilena Lopes</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Breckenfeld</surname>
            <given-names>Marcelle Parente</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Costa</surname>
            <given-names>Igor Santos</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Sousa</surname>
            <given-names>Ant&#xF4;nio Ren&#xEA; Di&#xF3;genes</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gon&#xE7;alves</surname>
            <given-names>Heitor de S&#xE1;</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">4</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label> Resident physician, second year Dermatology Residency of the Dermatology
Department of the Dona Lib&#xE2;nia Dermatology Center (CDERM) &#x2013; Fortaleza (CE), Brazil</aff>
      <aff id="aff2"><label>2</label> MD Pathologist, Dermatopathology Preceptor in the Dermatology Department
of the Dona Lib&#xE2;nia Dermatology Center (CDERM) &#x2013; Fortaleza (CE), Brazil</aff>
      <aff id="aff3"><label>3</label> Dermatologist Physician and Coordinator of the Dermatology Residency in
the Dermatology Department of the Dona Lib&#xE2;nia Dermatology Center (CDERM) &#x2013; Fortaleza
(CE), Brazil</aff>
      <aff id="aff4"><label>4</label> Director and Dermatologist Physician of the Dona Lib&#xE2;nia Dermatology
Center (CDERM) &#x2013; Fortaleza (CE), Brazil</aff>
      <author-notes>
        <corresp id="c01"><bold>Mailing address:</bold> Paula Azevedo Borges Leal - Rua Pedro I, 1033 - Centro
- 60035-101, Fortaleza, CE - Brazil - E-mail: <email>lealpauladl@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Mar-Apr</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>2</issue>
      <fpage>256</fpage>
      <lpage>259</lpage>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>1</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>4</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2013 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly
cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Rosai-Dorfman disease is a benign, self-limited, idiopathic proliferative histiocytic
disorder. It was first described in 1969 by Rosai and Dorfman. In its typical form
the disease is characterized by extensive cervical lymphadenopathy associated with
fever, polyclonal gammopathy and leukocytosis with neutrophilia. The skin is the most
common site affected. Extranodal manifestations have been reported in 43% of cases.
In this study, we report an atypical case of Rosai-Dorfman disease in a female with
massive cutaneous manifestation on the thigh, associated with a minimal
lymphadenopathy limited to the regional inguinal lymph nodes.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>A doen&#xE7;a de Rosai-Dorfman &#xE9; uma desordem benigna, autolimitada, idiop&#xE1;tica,
decorrente da prolifera&#xE7;&#xE3;o de histi&#xF3;citos. Foi descrita pela primeira vez por Rosai e
Dorfman em 1969. Tipicamente, a doen&#xE7;a se caracteriza por extensa linfadenopatia
cervical, febre, gamopatia monoclonal e leucocitose com neutrofilia. Manifesta&#xE7;&#xF5;es
extranodais s&#xE3;o encontradas em 43% dos casos, sendo a pele o s&#xED;tio extranodal mais
comumente afetado. No trabalho, apresentamos um caso de doen&#xE7;a de Rosai-Dorfman com
apresenta&#xE7;&#xE3;o cut&#xE2;nea exuberante na coxa direita e discreto comprometimento linfonodal
limitado &#xE0; cadeia regional.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Emperipolesis</kwd>
        <kwd>Histiocytosis</kwd>
        <kwd>Histiocytosis, non-langerhans-cell</kwd>
        <kwd>Histiocytosis, sinus</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Sinus histiocytosis with massive lymphadenopathy (SHML) was recognized by Rosai and
Dorfman in 1969 as a benign and self-limiting disease. It was characterized by extensive
cervical lymphadenopathy associated with fever, polyclonal gammopathy, and leukocytosis
with neutrophilia.<sup><xref ref-type="bibr" rid="r01">1</xref></sup> SHML or Rosai Dorfman disease (RDD) is a rare pseudolymphomatous disorder of
unknown etiology which is classified as non-Langerhans cell histiocytosis. The disease
can affect any age group but young adult men are more susceptible to it; however, it
rarely affects people of Asian origin. <sup><xref ref-type="bibr" rid="r02">2</xref></sup>
</p>
      <p>In its typical form, lymphadenopathy is bilateral, massive and painless, commonly
affecting the cervical lymph nodes. <sup><xref ref-type="bibr" rid="r03">3</xref></sup> Extranodal manifestations have been reported in 43% of cases, with the skin
being most frequently affected. <sup><xref ref-type="bibr" rid="r04">4</xref></sup> But, RDD only involves both nodal and extranodal sites in 28% of patients. <sup><xref ref-type="bibr" rid="r05">5</xref></sup> In this study, we report an atypical case of Rosai- Dorfman disease in a female
with massive cutaneous manifestation on the thigh, associated with a minimal
lymphadenopathy limited to the regional inguinal lymph nodes. </p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 43-year-old woman, mulatto, reported the appearance of an asymptomatic tumor on her
right thigh, which she had had for about 11 months. No comorbidities were reported. </p>
      <p>The examination revealed an indurated hyper-pigmented plaque with reddish-yellow
nodules, on her right thigh, measuring 15 cm in diameter (<xref ref-type="fig" rid="f01">Figure 1</xref>). An erythematous nodule was presented on her right buttock (<xref ref-type="fig" rid="f02">Figure 2</xref>). The patient reported that these lesions
were painless. A painless inguinal lymph node on the same side of the skin lesions was
also revealed upon examination. </p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Indurated hyperpigmented plaque with reddish-yellow nodules on the right thigh</p>
        </caption>
        <graphic xlink:href="abd-88-0256-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Erythematous nodule on the right buttock</p>
        </caption>
        <graphic xlink:href="abd-88-0256-g02"/>
      </fig>
      <p>The histopathology of the skin lesion exhibited a slightly acanthotic epidermis, dermis
and hypodermis with a diffuse infiltrate, consisting of lymphocytes, plasma cells and
neutrophils (<xref ref-type="fig" rid="f03">Figure 3</xref>). Occasional histiocytes
containing intact inflammatory cells within the cytoplasm (emperipolesis) were also seen
(<xref ref-type="fig" rid="f04">Figure 4</xref>). Immunohistochemical studies
revealed histiocytes with positivity for S100 and CD68 and negativity for CD1a. The
histopathology of the inguinal lymph node showed dilated nodal sinuses with large
numbers of histiocytes exhibiting emperipolesis (<xref ref-type="fig" rid="f05">Figure
5</xref>). </p>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Skin biopsy. Difuse dermal infiltrates of histiocytes, lymphocytes, neutrophils
and plasma cells. (H&amp;E stain, X100)</p>
        </caption>
        <graphic xlink:href="abd-88-0256-g03"/>
      </fig>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>Skin biopsy. Few histiocytes with emperipolesis. (H&amp;E stain, X400)</p>
        </caption>
        <graphic xlink:href="abd-88-0256-g04"/>
      </fig>
      <fig id="f05" orientation="portrait" position="float">
        <label>FIGURE 5</label>
        <caption>
          <p>Lymph node biopsy. Dilated nodal sinuses with large amount of histiocytes
exhibiting emperipolesis. (H&amp;E stain; X200, inset: X400)</p>
        </caption>
        <graphic xlink:href="abd-88-0256-g05"/>
      </fig>
      <p>Laboratory finds were microcytic anemia and polyclonal hypergammaglobulinemia. The image
tests (ultrasound and CT) showed a marked thickening of the skin and the subcutaneous
tissue located in the anterolateral region of the right thigh; enlarged lymph nodes up
to 2cm long located in the right inguinal chain; a normal-sized liver with the rare
presence of homogeneous cysts of 0.5cm. The myelogram was normal. </p>
      <p>The patient was referred to the oncology service for surgical treatment. </p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Sinus histiocytosis with massive lymphadenopathy is a rare self-limited
pseudolymphomatous disorder of unknown etiology. The disorder is usually characterized
by benign, extensive, cervical lymphadenopathy, accompanied by fever, poly-clonal
gammopathy and leukocytosis with neutrophilia. <sup><xref ref-type="bibr" rid="r03">3</xref></sup>
</p>
      <p>The histopathological features of SHML were first described in 1965 by Destombes. Four
years later, SHML was recognized as a clinicopathological entity by Rosai and Dorfman.
<sup><xref ref-type="bibr" rid="r01">1</xref></sup> By 1988, as it became evident that other nodal and extranodal sites could also
be affected and the term Rosai-Dorfman disease (RDD) was preferred. <sup><xref ref-type="bibr" rid="r05">5</xref></sup>
</p>
      <p>RRD affects all age groups, but predominantly people in the first and second decades of
life. Males are slightly more susceptible to the disorder and it rarely affects people
of Asian origin.
<sup><xref ref-type="bibr" rid="r05">2</xref>,<xref ref-type="bibr" rid="r04">4</xref></sup> Lymphadenodopathy appears in 87% of the patients and is often cervical,
bilateral, massive and painless. Inguinal (25.6%), axilary (23.7%) and mediastinal lymph
nodes (14.5%) may also be involved. <sup><xref ref-type="bibr" rid="r03">3</xref></sup> But RDD only involves both nodal and extranodal sites in 28% of patients. <sup><xref ref-type="bibr" rid="r05">5</xref></sup> Extranodal manifestations have been reported in 43% of cases and the skin is the
most common site affected. <sup><xref ref-type="bibr" rid="r04">4</xref></sup> Cutaneous manifestations are varied and appear as single or multiple maculae,
papules, plaques or nodules, with colors ranging from red-brown to yellow. <sup><xref ref-type="bibr" rid="r01">1</xref></sup>
</p>
      <p>The classic histopathological features of RDD are dense diffuse or nodular infiltrates
of foamy histiocytes, mixed with lymphocytes and plasma cells exhibiting emperipolesis.
In emperipolesis, lymphocytes, plasma cells or neutrophils are captured but not digested
by histiocytes. These specific types of histiocytes are called Rosai-Dorfman cells. The
lymph nodes show capsular fibrosis and dilated nodal sinuses filled with foamy
histiocytes that can exhibit emperipolesis. <sup><xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r06">6</xref></sup> The histologic finds of cutaneous RDD are less obvious than those seen in the
lymph nodes. Emperipolesis may be less conspicuous. <sup><xref ref-type="bibr" rid="r07">7</xref></sup> Immunohistochemical testing shows strong and consistent positivity for S-100
protein and for CD68, but not for CD 1a. <sup><xref ref-type="bibr" rid="r01">1</xref></sup> The patient displayed all of these histopathological features and the rendered
diagnosis was RDD. </p>
      <p>Owing to the variety of cutaneous manifestations of RDD, the differential diagnosis of
the disorder affecting the skin is complex and must include cutaneous lymphoid
hyperplasia, granuloma annulare, lymphocytic infiltrate of Jessner, interstitial
granulomatous dermatitis, histiocytoma, Langerhans cell histiocytosis, lymphomas,
melanoma and metastatic carcinomas. The diagnosis is more complex when the skin is the
only organ affected or when there are minimal clinical signs of lymphadenopathy. <sup><xref ref-type="bibr" rid="r08">8</xref>,<xref ref-type="bibr" rid="r09">9</xref></sup>
</p>
      <p>The etiology of RDD remains unknown, but two hypotheses have been proposed as follows: a
disturbance of cell-mediated immunity and a primary viral infection. Activated
macrophages have been found in immunohistochemical tests. <sup><xref ref-type="bibr" rid="r05">5</xref></sup> In addition, several reports have identified human herpes virus 6 and
Epstein-Barr virus in visceral and cutaneous lesions, although the viral genesis could
not be confirmed so far. RDD can be associated with immune-mediated disease and seems to
have a less favorable prognosis in these cases. <sup><xref ref-type="bibr" rid="r01">1</xref></sup>
</p>
      <p>Treatment depends on clinical manifestations. In many cases the lesions remain
asymptomatic and heal naturally without requiring any treatment. However, the condition
may be chronic with disseminated nodal, systemic involvement or destructive cutaneous
lesions. Therapeutic modalities include corticosteroids, criotherapy, radiotherapy,
surgery, high-dose thalidomide and alkylating agentes. <sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r09">9</xref></sup>
</p>
      <p>In the described case, the exuberance of the cutaneous lesion and the absence of massive
lymph node involvement made diagnosis difficult. The histopathological finds were
essential for elucidation of the case. Despite the benign and self-limited disease, the
patient presented severe cutaneous manifestation with chronic and progressive course,
requiring more aggressive therapy.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <p>* Study conducted at the Dona Lib&#xE2;nia Dermatology Center (CDERM) - Fortaleza (CE),
Brazil.</p>
      </fn>
      <fn id="fn02" fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn id="fn03" fn-type="financial-disclosure">
        <p>Financial funding: None</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Becker</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gaiser</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Middel</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rompel</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Clinicopathologic challenge. Destombes-Rosai-Dorfman
disease (DRDD) (sinushistiocytosis with massive lymphadenopathy)</article-title>
          <source>Int J Dermatol</source>
          <year>2008</year>
          <volume>47</volume>
          <fpage>125</fpage>
          <lpage>127</lpage>
          <pub-id pub-id-type="pmid">18211480</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Landim</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Rios</surname>
              <given-names>Hde O</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>CO</given-names>
            </name>
            <name>
              <surname>Feitosa</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Rocha</surname>
              <given-names>FD</given-names>
              <suffix>Filho</suffix>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>AA</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous Rosai-Dorfman disease</article-title>
          <source>An Bras Dermatol</source>
          <year>2009</year>
          <volume>84</volume>
          <fpage>275</fpage>
          <lpage>278</lpage>
          <pub-id pub-id-type="pmid">19668942</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>LY</given-names>
            </name>
            <name>
              <surname>Kou</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>HL</given-names>
            </name>
          </person-group>
          <article-title>Extranodal Rosai-Dorfman disease with cutaneous,
ophthalmic and laryngeal involvement: report of a case treated with
isotretinoin</article-title>
          <source>Int J Dermatol</source>
          <year>2002</year>
          <volume>41</volume>
          <fpage>888</fpage>
          <lpage>891</lpage>
          <pub-id pub-id-type="pmid">12492979</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gebhardt</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Averbeck</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Paasch</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Ugurel</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kurzen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Stumpp</surname>
              <given-names>P</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>A case of cutaneous Rosai-Dorfman disease refractory to
imatinib therapy</article-title>
          <source>Arch Dermatol</source>
          <year>2009</year>
          <volume>145</volume>
          <fpage>571</fpage>
          <lpage>574</lpage>
          <pub-id pub-id-type="pmid">19451502</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pitamber</surname>
              <given-names>HV</given-names>
            </name>
            <name>
              <surname>Grayson</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Five case of cutaneous Rosai-Dorfman
disease</article-title>
          <source>Clin Exp Dermatol</source>
          <year>2003</year>
          <volume>28</volume>
          <fpage>17</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">12558621</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>WY</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>HN</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>CH</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous Rosai-Dorfman disease: clinicopathological
profiles, spectrum and evolution of 21 lesions in six patients</article-title>
          <source>Br J Dermatol</source>
          <year>2006</year>
          <volume>154</volume>
          <fpage>277</fpage>
          <lpage>286</lpage>
          <pub-id pub-id-type="pmid">16433797</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kroumpouzos</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Demierre</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous Rosai-Dorfman disease: histopathological
presentation as inflammatory pseudotumor. A literature review</article-title>
          <source>Acta Derm Venereol</source>
          <year>2002</year>
          <issue>82</issue>
          <fpage>292</fpage>
          <lpage>296</lpage>
          <pub-id pub-id-type="pmid">12361136</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uniyal</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Beena</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Ramesh</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Mukherjee</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous Rosai-Dorfman disease preceding inguinal
lymphadenopathy</article-title>
          <source>Int J Dermatol</source>
          <year>2002</year>
          <volume>41</volume>
          <fpage>404</fpage>
          <lpage>406</lpage>
          <pub-id pub-id-type="pmid">12121554</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Chu</surname>
              <given-names>CY</given-names>
            </name>
          </person-group>
          <article-title>Dapsone as a potential treatment for cultaneous
Rosai-Dorfman disease with neutrophilic predominance</article-title>
          <source>Arch Dermatol</source>
          <year>2006</year>
          <volume>142</volume>
          <fpage>428</fpage>
          <lpage>430</lpage>
          <pub-id pub-id-type="pmid">16618860</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
